3 Results for "

NIR178

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NIR178" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-109139
CAS No.: 1337962-47-6
Purity:  99.84%
Synonyms: NIR178; PBF509
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease Cancer

Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response .
loading...
    loading...
Cat. No.: HY-109139A
CAS No.: 2253894-81-2
Synonyms: NIR178 mesylate; PBF509 mesylate
Target:  

Adenosine Receptor

Research Areas:  

Cancer

Taminadenant mesylate (NIR178 mesylate) is a potent adenosine A2A receptor antagonist with potential anti-tumor activity. Taminadenant mesylate can selectively bind and inhibit A2AR on T lymphocytes, thereby releasing adenosine/A2AR-mediated inhibition of T lymphocytes and activating T cell-mediated immune responses against tumor cells. Taminadenant mesylate works by reducing the proliferation of susceptible tumor cells. Taminadenant mesylate also showed effectiveness in reversing dyskinesias in Parkinson's disease models and was able to inhibit dyskinesias caused by L-DOPA .
loading...
    loading...
Cat. No.: HY-109139R
CAS No.: 1337962-47-6
Synonyms: NIR178 (Standard); PBF509 (Standard)
Taminadenant (Standard) is the analytical standard of Taminadenant (HY-109139). This product is intended for research and analytical applications. Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparKinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response .
loading...
    loading...